NVP-BKM120 is a potent, selective, orally bioavailable Class I PI3Kα Inhibitor with IC50 of 20nM, currently in phase II clinical trials for the treatment of cancer. It exhibits lower potency against class III and class IV PI3Ks.
Product Specification
| Alternative Name: | Buparlisib, NVP-BKM120 |
| |
| Formula: | C18H21F3N6O2 |
| |
| MW: | 410.4 |
| |
| CAS: | 944396-07-0 |
| |
| Purity: | ≥97% (HPLC) |
| |
| Identity: | Determined by EM-MS, NMR |
| |
| Appearance: | White powder. |
| |
| Solubility: | Soluble in DMSO (44mg/ml) or ethanol (<1mg/ml). |
| |
| Shipping: | Ambient |
| |
| Short Term Storage: | +4°C |
| |
| Long Term Storage: | -20°C |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
